|
Volumn 12, Issue 3, 2001, Pages 239-243
|
Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A165 plasmid in patients with inoperable angina pectoris
|
Author keywords
Coronary artery disease; Doppler; Human; Perfusion; Plasmid; Thoracotomy; VEGF
|
Indexed keywords
VASCULOTROPIN ANTIBODY;
ADULT;
AGED;
ANGINA PECTORIS;
ARTICLE;
BLOOD FLOW VELOCITY;
CELL VIABILITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DOPPLER ECHOCARDIOGRAPHY;
DRUG EFFECT;
FEMALE;
GENE THERAPY;
HEART MUSCLE CELL;
HUMAN;
MALE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PLASMID;
PRIORITY JOURNAL;
STRESS ECHOCARDIOGRAPHY;
THORACOTOMY;
AGED;
ANGINA PECTORIS;
CORONARY CIRCULATION;
ECHOCARDIOGRAPHY, DOPPLER;
ENDOTHELIAL GROWTH FACTORS;
GENE THERAPY;
HUMANS;
MIDDLE AGED;
PLASMIDS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 0035030237
PISSN: 09546928
EISSN: None
Source Type: Journal
DOI: 10.1097/00019501-200105000-00010 Document Type: Article |
Times cited : (35)
|
References (9)
|